Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Structural and Functional Characterization of the Type Three Secretion System (T3SS) Needle of Pseudomonas aeruginosa.

Lombardi C, Tolchard J, Bouillot S, Signor L, Gebus C, Liebl D, Fenel D, Teulon JM, Brock J, Habenstein B, Pellequer JL, Faudry E, Loquet A, Attrée I, Dessen A, Job V.

Front Microbiol. 2019 Mar 29;10:573. doi: 10.3389/fmicb.2019.00573. eCollection 2019.

2.

Insertion sequences drive the emergence of a highly adapted human pathogen.

Sentausa E, Basso P, Berry A, Adrait A, Bellement G, Couté Y, Lory S, Elsen S, Attrée I.

Microb Genom. 2019 Apr 4. doi: 10.1099/mgen.0.000265. [Epub ahead of print]

3.

cAMP and Vfr Control Exolysin Expression and Cytotoxicity of Pseudomonas aeruginosa Taxonomic Outliers.

Berry A, Han K, Trouillon J, Robert-Genthon M, Ragno M, Lory S, Attrée I, Elsen S.

J Bacteriol. 2018 May 24;200(12). pii: e00135-18. doi: 10.1128/JB.00135-18. Print 2018 Jun 15.

4.

Assembly of an atypical α-macroglobulin complex from Pseudomonas aeruginosa.

Zouhir S, Robert-Genthon M, Trindade DM, Job V, Nedeljković M, Breyton C, Ebel C, Attrée I, Dessen A.

Sci Rep. 2018 Jan 11;8(1):527. doi: 10.1038/s41598-017-18083-6.

5.

CLIQ-BID: A method to quantify bacteria-induced damage to eukaryotic cells by automated live-imaging of bright nuclei.

Wallez Y, Bouillot S, Soleilhac E, Huber P, Attrée I, Faudry E.

Sci Rep. 2018 Jan 8;8(1):5. doi: 10.1038/s41598-017-18501-9.

6.

Exolysin Shapes the Virulence of Pseudomonas aeruginosa Clonal Outliers.

Reboud E, Basso P, Maillard AP, Huber P, Attrée I.

Toxins (Basel). 2017 Nov 9;9(11). pii: E364. doi: 10.3390/toxins9110364. Review.

7.

Pseudomonas aeruginosa ExlA and Serratia marcescens ShlA trigger cadherin cleavage by promoting calcium influx and ADAM10 activation.

Reboud E, Bouillot S, Patot S, Béganton B, Attrée I, Huber P.

PLoS Pathog. 2017 Aug 23;13(8):e1006579. doi: 10.1371/journal.ppat.1006579. eCollection 2017 Aug.

8.

Defining Lipoprotein Localisation by Fluorescence Microscopy.

Casabona MG, Robert-Genthon M, Grunwald D, Attrée I.

Methods Mol Biol. 2017;1615:65-74. doi: 10.1007/978-1-4939-7033-9_4.

PMID:
28667602
9.

Multiple Pseudomonas species secrete exolysin-like toxins and provoke Caspase-1-dependent macrophage death.

Basso P, Wallet P, Elsen S, Soleilhac E, Henry T, Faudry E, Attrée I.

Environ Microbiol. 2017 Oct;19(10):4045-4064. doi: 10.1111/1462-2920.13841. Epub 2017 Jul 26.

PMID:
28654176
10.

Pseudomonas aeruginosa Exolysin promotes bacterial growth in lungs, alveolar damage and bacterial dissemination.

Bouillot S, Munro P, Gallet B, Reboud E, Cretin F, Golovkine G, Schoehn G, Attrée I, Lemichez E, Huber P.

Sci Rep. 2017 May 18;7(1):2120. doi: 10.1038/s41598-017-02349-0.

11.

Pseudomonas aeruginosa Pore-Forming Exolysin and Type IV Pili Cooperate To Induce Host Cell Lysis.

Basso P, Ragno M, Elsen S, Reboud E, Golovkine G, Bouillot S, Huber P, Lory S, Faudry E, Attrée I.

MBio. 2017 Jan 24;8(1). pii: e02250-16. doi: 10.1128/mBio.02250-16.

12.

Pseudomonas aeruginosa renews its virulence factors.

Huber P, Basso P, Reboud E, Attrée I.

Environ Microbiol Rep. 2016 Oct;8(5):564-571. doi: 10.1111/1758-2229.12443. Epub 2016 Aug 25. Review.

PMID:
27428387
13.

Phenotype and toxicity of the recently discovered exlA-positive Pseudomonas aeruginosa strains collected worldwide.

Reboud E, Elsen S, Bouillot S, Golovkine G, Basso P, Jeannot K, Attrée I, Huber P.

Environ Microbiol. 2016 Oct;18(10):3425-3439. doi: 10.1111/1462-2920.13262. Epub 2016 Apr 21.

PMID:
26914644
14.

Pseudomonas aeruginosa Transmigrates at Epithelial Cell-Cell Junctions, Exploiting Sites of Cell Division and Senescent Cell Extrusion.

Golovkine G, Faudry E, Bouillot S, Elsen S, Attrée I, Huber P.

PLoS Pathog. 2016 Jan 4;12(1):e1005377. doi: 10.1371/journal.ppat.1005377. eCollection 2016 Jan.

15.

Pharmacological activation of Rap1 antagonizes the endothelial barrier disruption induced by exotoxins ExoS and ExoT of Pseudomonas aeruginosa.

Bouillot S, Attrée I, Huber P.

Infect Immun. 2015 May;83(5):1820-9. doi: 10.1128/IAI.00010-15. Epub 2015 Feb 17.

16.

ExsB is required for correct assembly of the Pseudomonas aeruginosa type III secretion apparatus in the bacterial membrane and full virulence in vivo.

Perdu C, Huber P, Bouillot S, Blocker A, Elsen S, Attrée I, Faudry E.

Infect Immun. 2015 May;83(5):1789-98. doi: 10.1128/IAI.00048-15. Epub 2015 Feb 17.

17.

PscI is a type III secretion needle anchoring protein with in vitro polymerization capacities.

Monlezun L, Liebl D, Fenel D, Grandjean T, Berry A, Schoehn G, Dessein R, Faudry E, Attree I.

Mol Microbiol. 2015 Apr;96(2):419-36. doi: 10.1111/mmi.12947. Epub 2015 Feb 26.

18.

Pseudomonas aeruginosa Genome Evolution in Patients and under the Hospital Environment.

Lucchetti-Miganeh C, Redelberger D, Chambonnier G, Rechenmann F, Elsen S, Bordi C, Jeannot K, Attrée I, Plésiat P, de Bentzmann S.

Pathogens. 2014 Apr 10;3(2):309-40. doi: 10.3390/pathogens3020309.

19.

A gacS deletion in Pseudomonas aeruginosa cystic fibrosis isolate CHA shapes its virulence.

Sall KM, Casabona MG, Bordi C, Huber P, de Bentzmann S, Attrée I, Elsen S.

PLoS One. 2014 Apr 29;9(4):e95936. doi: 10.1371/journal.pone.0095936. eCollection 2014.

20.

Metabolism: pathogens love the poison.

Ménage S, Attrée I.

Nat Chem Biol. 2014 May;10(5):326-7. doi: 10.1038/nchembio.1505. No abstract available.

PMID:
24743254
21.

VE-cadherin cleavage by LasB protease from Pseudomonas aeruginosa facilitates type III secretion system toxicity in endothelial cells.

Golovkine G, Faudry E, Bouillot S, Voulhoux R, Attrée I, Huber P.

PLoS Pathog. 2014 Mar 13;10(3):e1003939. doi: 10.1371/journal.ppat.1003939. eCollection 2014 Mar.

22.

A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.

Elsen S, Huber P, Bouillot S, Couté Y, Fournier P, Dubois Y, Timsit JF, Maurin M, Attrée I.

Cell Host Microbe. 2014 Feb 12;15(2):164-76. doi: 10.1016/j.chom.2014.01.003.

23.

Membrane and chaperone recognition by the major translocator protein PopB of the type III secretion system of Pseudomonas aeruginosa.

Discola KF, Förster A, Boulay F, Simorre JP, Attree I, Dessen A, Job V.

J Biol Chem. 2014 Feb 7;289(6):3591-601. doi: 10.1074/jbc.M113.517920. Epub 2013 Dec 2.

24.

Sequential inactivation of Rho GTPases and Lim kinase by Pseudomonas aeruginosa toxins ExoS and ExoT leads to endothelial monolayer breakdown.

Huber P, Bouillot S, Elsen S, Attrée I.

Cell Mol Life Sci. 2014 May;71(10):1927-41. doi: 10.1007/s00018-013-1451-9. Epub 2013 Aug 22.

PMID:
23974244
25.

Unique features of a Pseudomonas aeruginosa α2-macroglobulin homolog.

Robert-Genthon M, Casabona MG, Neves D, Couté Y, Cicéron F, Elsen S, Dessen A, Attrée I.

MBio. 2013 Aug 6;4(4). pii: e00309-13. doi: 10.1128/mBio.00309-13.

26.

Intraclonal genome diversity of Pseudomonas aeruginosa clones CHA and TB.

Bezuidt OK, Klockgether J, Elsen S, Attree I, Davenport CF, Tümmler B.

BMC Genomics. 2013 Jun 22;14:416. doi: 10.1186/1471-2164-14-416.

27.

Proteomic characterization of Pseudomonas aeruginosa PAO1 inner membrane.

Casabona MG, Vandenbrouck Y, Attree I, Couté Y.

Proteomics. 2013 Aug;13(16):2419-23. doi: 10.1002/pmic.201200565. Epub 2013 Jul 17.

PMID:
23744604
28.

Current fluctuation analysis of the PopB and PopD translocon components of the Pseudomonas aeruginosa type III secretion system.

Wager B, Faudry E, Wills T, Attree I, Delcour AH.

Biophys J. 2013 Apr 2;104(7):1445-55. doi: 10.1016/j.bpj.2013.02.018.

29.

Pore formation by T3SS translocators: liposome leakage assay.

Faudry E, Perdu C, Attrée I.

Methods Mol Biol. 2013;966:173-85. doi: 10.1007/978-1-62703-245-2_11.

PMID:
23299735
30.

Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB.

de Bentzmann S, Giraud C, Bernard CS, Calderon V, Ewald F, Plésiat P, Nguyen C, Grunwald D, Attree I, Jeannot K, Fauvarque MO, Bordi C.

PLoS Pathog. 2012;8(11):e1003052. doi: 10.1371/journal.ppat.1003052. Epub 2012 Nov 29. Erratum in: PLoS Pathog. 2012 Dec;8(12). doi: 10.1371/annotation/5c169544-7d19-40db-9a58-28b2fdf2c82c.

31.

An ABC transporter and an outer membrane lipoprotein participate in posttranslational activation of type VI secretion in Pseudomonas aeruginosa.

Casabona MG, Silverman JM, Sall KM, Boyer F, Couté Y, Poirel J, Grunwald D, Mougous JD, Elsen S, Attree I.

Environ Microbiol. 2013 Feb;15(2):471-86. doi: 10.1111/j.1462-2920.2012.02816.x. Epub 2012 Jul 6.

32.

Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa.

Gendrin C, Contreras-Martel C, Bouillot S, Elsen S, Lemaire D, Skoufias DA, Huber P, Attree I, Dessen A.

PLoS Pathog. 2012;8(4):e1002637. doi: 10.1371/journal.ppat.1002637. Epub 2012 Apr 5.

33.

Injection of Pseudomonas aeruginosa Exo toxins into host cells can be modulated by host factors at the level of translocon assembly and/or activity.

Verove J, Bernarde C, Bohn YS, Boulay F, Rabiet MJ, Attree I, Cretin F.

PLoS One. 2012;7(1):e30488. doi: 10.1371/journal.pone.0030488. Epub 2012 Jan 27.

34.

Structural characterization and membrane localization of ExsB from the type III secretion system (T3SS) of Pseudomonas aeruginosa.

Izoré T, Perdu C, Job V, Attree I, Faudry E, Dessen A.

J Mol Biol. 2011 Oct 14;413(1):236-46. doi: 10.1016/j.jmb.2011.07.043. Epub 2011 Aug 4.

PMID:
21839744
35.

PtrA is a periplasmic protein involved in Cu tolerance in Pseudomonas aeruginosa.

Elsen S, Ragno M, Attree I.

J Bacteriol. 2011 Jul;193(13):3376-8. doi: 10.1128/JB.00159-11. Epub 2011 Apr 29.

36.

Membrane targeting and pore formation by the type III secretion system translocon.

Matteï PJ, Faudry E, Job V, Izoré T, Attree I, Dessen A.

FEBS J. 2011 Feb;278(3):414-26. doi: 10.1111/j.1742-4658.2010.07974.x. Epub 2010 Dec 23. Review.

37.

Cochaperone interactions in export of the type III needle component PscF of Pseudomonas aeruginosa.

Plé S, Job V, Dessen A, Attree I.

J Bacteriol. 2010 Jul;192(14):3801-8. doi: 10.1128/JB.00117-10. Epub 2010 May 21.

38.

Structural basis of chaperone recognition of type III secretion system minor translocator proteins.

Job V, Matteï PJ, Lemaire D, Attree I, Dessen A.

J Biol Chem. 2010 Jul 23;285(30):23224-32. doi: 10.1074/jbc.M110.111278. Epub 2010 Apr 12.

39.

Anti-activator ExsD forms a 1:1 complex with ExsA to inhibit transcription of type III secretion operons.

Thibault J, Faudry E, Ebel C, Attree I, Elsen S.

J Biol Chem. 2009 Jun 5;284(23):15762-70. doi: 10.1074/jbc.M109.003533. Epub 2009 Apr 15.

40.

Dissecting the bacterial type VI secretion system by a genome wide in silico analysis: what can be learned from available microbial genomic resources?

Boyer F, Fichant G, Berthod J, Vandenbrouck Y, Attree I.

BMC Genomics. 2009 Mar 12;10:104. doi: 10.1186/1471-2164-10-104.

41.

Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.

Vettoretti L, Plésiat P, Muller C, El Garch F, Phan G, Attrée I, Ducruix A, Llanes C.

Antimicrob Agents Chemother. 2009 May;53(5):1987-97. doi: 10.1128/AAC.01024-08. Epub 2009 Mar 2.

42.

Oligomerization of PcrV and LcrV, protective antigens of Pseudomonas aeruginosa and Yersinia pestis.

Gébus C, Faudry E, Bohn YS, Elsen S, Attree I.

J Biol Chem. 2008 Aug 29;283(35):23940-9. doi: 10.1074/jbc.M803146200. Epub 2008 Jun 26. Erratum in: J Biol Chem. 2009 Aug 7;284(32):21776. Caroline, Gébus [corrected to Gébus, Caroline]; Eric, Faudry [corrected to Faudry, Eric]; Sylvie, Elsen [corrected to Elsen, Sylvie].

43.

Resistance and virulence of Pseudomonas aeruginosa clinical strains overproducing the MexCD-OprJ efflux pump.

Jeannot K, Elsen S, Köhler T, Attree I, van Delden C, Plésiat P.

Antimicrob Agents Chemother. 2008 Jul;52(7):2455-62. doi: 10.1128/AAC.01107-07. Epub 2008 May 12.

44.

Pseudomonas aeruginosa virulence genes identified in a Dictyostelium host model.

Alibaud L, Köhler T, Coudray A, Prigent-Combaret C, Bergeret E, Perrin J, Benghezal M, Reimmann C, Gauthier Y, van Delden C, Attree I, Fauvarque MO, Cosson P.

Cell Microbiol. 2008 Mar;10(3):729-40. Epub 2007 Nov 27.

PMID:
18042255
45.

Type III secretion system translocator has a molten globule conformation both in its free and chaperone-bound forms.

Faudry E, Job V, Dessen A, Attree I, Forge V.

FEBS J. 2007 Jul;274(14):3601-3610. doi: 10.1111/j.1742-4658.2007.05893.x. Epub 2007 Jun 18.

46.

Structure of the heterotrimeric complex that regulates type III secretion needle formation.

Quinaud M, Plé S, Job V, Contreras-Martel C, Simorre JP, Attree I, Dessen A.

Proc Natl Acad Sci U S A. 2007 May 8;104(19):7803-8. Epub 2007 Apr 30.

47.

Synergistic pore formation by type III toxin translocators of Pseudomonas aeruginosa.

Faudry E, Vernier G, Neumann E, Forge V, Attree I.

Biochemistry. 2006 Jul 4;45(26):8117-23.

PMID:
16800636
48.

PscF is a major component of the Pseudomonas aeruginosa type III secretion needle.

Pastor A, Chabert J, Louwagie M, Garin J, Attree I.

FEMS Microbiol Lett. 2005 Dec 1;253(1):95-101. Epub 2005 Oct 5.

49.

The PscE-PscF-PscG complex controls type III secretion needle biogenesis in Pseudomonas aeruginosa.

Quinaud M, Chabert J, Faudry E, Neumann E, Lemaire D, Pastor A, Elsen S, Dessen A, Attree I.

J Biol Chem. 2005 Oct 28;280(43):36293-300. Epub 2005 Aug 22.

50.

Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes.

Goure J, Broz P, Attree O, Cornelis GR, Attree I.

J Infect Dis. 2005 Jul 15;192(2):218-25. Epub 2005 Jun 7.

PMID:
15962216

Supplemental Content

Loading ...
Support Center